Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived 
D Riemann A Kehlen J Langner
Aminopeptidase N (APN) and dipeptidylpeptidase IV (DPIV) are transmembrane type II molecules widely distributed in mammalian tissues. In recent years, the interest in cell surface peptidases has increased considerably because, among other things, several ...
https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico
PubMed Central (PMC)
Clin Exp Immunol. 1995 May; 100(2): 277–283.

PMCID: PMC1534323

PMID: 7743667

Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.

Abstract

Aminopeptidase N (APN) and dipeptidylpeptidase IV (DPIV) are transmembrane type II molecules widely distributed in mammalian tissues. In recent years, the interest in cell surface peptidases has increased considerably because, among other things, several reports indicate roles of ectopeptidases in tumour cell metastasis. Investigations into the regulation of APN and DPIV on tumour cells are rare. We report, for the first time, that IL-4 and IL-13 can up-regulate protein expression as well as enzymatic activity of both the peptidases on renal carcinoma cells and renal tubular epithelial cells in culture. The analysis of mRNA by competitive polymerase chain reaction (PCR) confirmed our results with respect to the APN increase at the level of gene expression. IL-1 beta and tumour necrosis factor-alpha (TNF-alpha) augmented the IL-4-induced effect with respect to APN but not to DPIV. A 5-day incubation with interferon-gamma (IFN-gamma) increased protein expression, especially of APN and, to a lesser extent, also of DPIV, whereas no significant increase in enzymatic activity could be observed. Small concentrations of transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and enzyme activity of DPIV. IL-6, IL-7, IL-10 and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been found to be without any effect on APN and DPIV. For a prospective therapeutic regimen with T cell-derived cytokines it has to be considered that--besides their effect on tumour cell growth--cytokines might affect surface ectopeptidases involved in tumour cell adhesion processes. The inhibition of APN and DPIV could be a new approach to suppression of cancer spread.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Sanderink GJ, Artur Y, Siest G. Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem. 1988 Dec;26(12):795–807. [PubMed] [Google Scholar]

Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest. 1989 Apr;83(4):1299–1307. [PMC free article] [PubMed] [Google Scholar]

Heins J, Welker P, Schönlein C, Born I, Hartrodt B, Neubert K, Tsuru D, Barth A. Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum. Biochim Biophys Acta. 1988 May 18;954(2):161–169. [PubMed] [Google Scholar]

Ulmer AJ, Mattern T, Feller AC, Heymann E, Flad HD. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand J Immunol. 1990 Apr;31(4):429–435. [PubMed] [Google Scholar]

Stenzl A, deKernion JB. Pathology, biology, and clinical staging of renal cell carcinoma. Semin Oncol. 1989 Feb;16(1 Suppl 1):3–11. [PubMed] [Google Scholar]

Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 1990 Sep 1;50(17):5531–5536. [PubMed] [Google Scholar]

Piazza GA, Callanan HM, Mowery J, Hixson DC. Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J. 1989 Aug 15;262(1):327–334. [PMC free article] [PubMed] [Google Scholar]

Hanski C, Huhle T, Gossrau R, Reutter W. Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp Cell Res. 1988 Sep;178(1):64–72. [PubMed] [Google Scholar]

Bauvois B. A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. Biochem J. 1988 Jun 15;252(3):723–731. [PMC free article] [PubMed] [Google Scholar]

Menrad A, Speicher D, Wacker J, Herlyn M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res. 1993 Mar 15;53(6):1450–1455. [PubMed] [Google Scholar]

Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993 Apr 22;54(1):137–143. [PMC free article] [PubMed] [Google Scholar]

Hoon DS, Okun E, Banez M, Irie RF, Morton DL. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Cancer Res. 1991 Oct 15;51(20):5687–5693. [PubMed] [Google Scholar]

Hillman GG, Puri RK, Kukuruga MA, Pontes JE, Haas GP. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma. Clin Exp Immunol. 1994 Jun;96(3):476–483. [PMC free article] [PubMed] [Google Scholar]

Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. [PubMed] [Google Scholar]

Tieku S, Hooper NM. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol. 1992 Nov 3;44(9):1725–1730. [PMC free article] [PubMed] [Google Scholar]

Kotani T, Aratake Y, Ogata Y, Umeki K, Araki Y, Hirai K, Kuma K, Ohtaki S. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett. 1991 May 24;57(3):203–208. [PubMed] [Google Scholar]

Ino K, Goto S, Okamoto T, Nomura S, Nawa A, Isobe K, Mizutani S, Tomoda Y. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn J Cancer Res. 1994 Sep;85(9):927–933. [PMC free article] [PubMed] [Google Scholar]

Johnson RC, Zhu D, Augustin-Voss HG, Pauli BU. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J Cell Biol. 1993 Jun;121(6):1423–1432. [PMC free article] [PubMed] [Google Scholar]

Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med. 1993 Apr 1;177(4):1135–1143. [PMC free article] [PubMed] [Google Scholar]

Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. Cancer Res. 1990 Jul 15;50(14):4190–4194. [PubMed] [Google Scholar]

Gregg SL, Gajl-Peczalska KJ, LeBien TW, Bloomfield CD, Brunning R, Sagawa K. Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia. Cancer Res. 1984 Jun;44(6):2724–2730. [PubMed] [Google Scholar]

Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 1992 Jun;41(6):1571–1580. [PubMed] [Google Scholar]

Stefanovic V, Ardaillou N, Vlahovic P, Placier S, Ronco P, Ardaillou R. Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology. 1993 Nov;80(3):465–470. [PMC free article] [PubMed] [Google Scholar]

van Hal PT, Hopstaken-Broos JP, Prins A, Favaloro EJ, Huijbens RJ, Hilvering C, Figdor CG, Hoogsteden HC. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2). J Immunol. 1994 Sep 15;153(6):2718–2728. [PubMed] [Google Scholar]

Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992 Oct;90(4):1479–1485. [PMC free article] [PubMed] [Google Scholar]

Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991 May 1;77(9):1859–1870. [PubMed] [Google Scholar]

Van Hal PT, Hopstaken-Broos JP, Wijkhuijs JM, Te Velde AA, Figdor CG, Hoogsteden HC. Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. J Immunol. 1992 Aug 15;149(4):1395–1401. [PubMed] [Google Scholar]

de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol. 1993 Dec 1;151(11):6370–6381. [PubMed] [Google Scholar]

Kenny AJ, O'Hare MJ, Gusterson BA. Cell-surface peptidases as modulators of growth and differentiation. Lancet. 1989 Sep 30;2(8666):785–787. [PubMed] [Google Scholar]

Steger GG, Pierce WC, Figlin R, Czernin J, Kaboo R, DeKernion JB, Okarma T, Belldegrun A. Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo. Clin Immunol Immunopathol. 1994 Aug;72(2):237–247. [PubMed] [Google Scholar]

Schoof DD, Terashima Y, Peoples GE, Goedegebuure PS, Andrews JV, Richie JP, Eberlein TJ. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Cell Immunol. 1993 Aug;150(1):114–123. [PubMed] [Google Scholar]

Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest. 1993 Jan;91(1):88–93. [PMC free article] [PubMed] [Google Scholar]

Margolin K, Aronson FR, Sznol M, Atkins MB, Gucalp R, Fisher RI, Sunderland M, Doroshow JH, Ernest ML, Mier JW, et al. Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanoma. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):147–153. [PubMed] [Google Scholar]

Orosz P, Echtenacher B, Falk W, Rüschoff J, Weber D, Männel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med. 1993 May 1;177(5):1391–1398. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology